147
Views
47
CrossRef citations to date
0
Altmetric
Review

Antibiotic Prophylaxis in Children with Relapsing Urinary Tract Infections: Review

Pages 115-123 | Published online: 18 Jul 2013

REFERENCES

  • Bitar CN, Steele RW. Use of prophylactic antibiotics in children. Adv Pediatr Inf Dis 1995; 10: 227–262.
  • Nahata MC. Guidelines for antimicrobial prophylaxis. J Clin Pharm Ther 1996; 21 (4): 255–260.
  • Gaudelus J. Traitement préventif des infections urinaires de l'enfant. Arch Pediatrie 1998; 5, Suppl 3: 307–311.
  • Viganò A, Stasi P, Tommasi P. La profilassi antibiotica nelle infezioni delle vie urinarie. Riv Inf Ped 1990; 5,3: 123–130.
  • Kunin CM. Chemoprophylaxis and suppressive therapy in the management of urinary tract infections. J Antimicrob Chemother 1994; 33 ( Suppl A): 51-62.
  • Downs MD. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999; 103 (4): e54.
  • Chambers T. An assay on the consequences of child-hood urinary tract infections. Pediatr Nephrol 1997; 11: 178–179.
  • Jodal U, Winberg J. Management of children with unob-structed urinary tract infection. Drug Therap Bull 1997; 35 (9): 65–69.
  • Zelicovich I, Adelman RD, Nancarrow PA. Urinary tract infections in children. An update. West J Med 1992; 157: 554–561.
  • Cochat P, Cochat N. L'infection urinaire du nourisson: aspects medicaux. Pédiatrie 1991; 46: 521–526.
  • Eliakim A, Dolfin T, Kortzets Z, Walach B, Pomeranz A. Urinary tract infection in premature infants: the role of imaging studies and prophylactic therapy. J Perinatol 1997; 17 (4): 305–308.
  • Hoberman A, Wald ER. Urinary tract infections in young febrile children. Pediatr Infect Dis J 1997; 16 (1): 11–17.
  • Shaw KN, Gorelick M, McGowan KL, Yaskoe NM, Schwrtz JS. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics 1998; 102 (2): e16.
  • Rushton HG. Urinary tract infections in children. Epidemiology, evaluation, and management. Pediat Clin N Am 1997; 44 : 1133–1169.
  • Quinet B. Definition actuel de l'infection urinaire de l'enfant. Archs Pediat 1998; (Suppl. 3): 250-253.
  • Nash MA, Seigle RL. Urinary tract infections in infants and children. Advs Pediatr Infect Dis. Mosby-Yearbook, Inc. Vol 11, 1996: 403–448.
  • Fanos V, Khoory BJ. Antimicrobial survey on urinary tract isolated micro-organisms in a pediatric department. J Chemother 1999; 11, 4: 255–259.
  • Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4: 80–120.
  • Khoory BJ, Fanos V, Zavarise G, Mengarda F, Michielutti F, Dall'Agnola A. Infezioni delle vie urinarie in eta pediatrica: trattamento medico. Ii Pediatra, novembre 1996.
  • Roberts JA. Factors predisposing to urinary infections in children. Pediatr Nephrol 1996; 10: 517–521.
  • Wiswell TE, Smith FR, Bass JW. Decreased incidence of urinary tract infections in circumcised infants. Pediatrics 1985; 75: 901–903.
  • Hellerstein S. Urinary tract infections in children: why they occur and how to prevent them. Am Fam Phys 1998; 57 (10): 2440–2446.
  • Weiss RA. Update on childhood urinary tract infections and reflux. Semin Nephrol 1998; 18 (3): 264–269.
  • O'Regan S, Yazbeck S, Schick E. Constipation, bladder instability, urinary tract infection syndrome. Clin Nephrol 1985; 23: 152–154.
  • Koff SA, Wagner IT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesi-coureteral reflux and urinary tract infections in children. J Urol 1998; 160: 1019–1022.
  • Ahmed SM, Swedlund SK. Evaluation of urinary tract infections in children. Am Fam Phys 1998; 57 (7): 1573–1580.
  • Fanos V, Cataldi L. Antibacterial induced nephrotoxicity in the newborn. Drug Safety 1999; 20 (3): 245–267.
  • Shapiro ED. Infections of the urinary tract. Pediatr Infect Dis J 1992; 11: 165–168.
  • Fanos V, Dall'Agnola A. Antibiotic treatment of infections in neonates: a review. Drugs 1999; 58 (3): 405–427.
  • Starney TA, Condy M, Mihara G. Prophylactic effect of nitrofurantoin macrocrystals and trimethoprim, sulfamethoxa-zole in urinary infection. N Engl J Med 1977; 296 (2): 206–208.
  • Brumfitt W, Hamilton-Miller JM. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infections. Infection 1995; 23: 98–102.
  • Brumfitt W, Hamilton-Miller JM. Efficacy and safety profile of long term nitrofurantoin in urinary infections: 18 years experience. J Antimicrob Chemother 1998; 42 (3): 363–371.
  • Johnson HW, Anderson JD, Chambers GK, Arnold WJ. Irwin BJ, Brinton JR. A short term study of nitrofurantoin prophylaxis in children managed with clean intermittent catherization. Pediatrics 1994; 93 (5): 752–755.
  • Conagio MJ, Gross TP, Roscelli JD. Nitrofurantoin toxicity in children. Pediatr Infect Dis J 1989; 8: 163–166.
  • Grunenberg RN, Smellie JM, Leaky A. Long term low-dose cotrimoxazole in prophylaxis of childhood urinary tract infection. Bacteriologic aspects. Br Med J 1976; 2: 206–208.
  • Knothe H. A review of trimethoprim-sulphonamide, trimethoprim and sulphonamide on the occurrence of resistant enterobacteriaceae in human intestinal flora. Infection 1979; 7 Suppl 4: S321–3.
  • Perazzella M, Mahnemanit R. Trimethoprim-sul-famethoxazole hyperkaliemia is an important complication regardless of the dose. Clin Nephrol 1996; 48: 187–192.
  • Smith EM, Elder J. Double antimicrobial prophylaxis in girls with breakthrough urinary tract infections. Pediatr Urol, 1994; 43 (5): 708–713.
  • Vu-Thien H. Sensibilité aux antibiotiques des bactéries isolées dans les infections urinaries en pediatrie. Archs Pediat 1998; 5 (Suppl. 3): 266-268.
  • Seracini D, Materassi M, Danti A. Studio aperto non comparativo sull'efficacia e tollerabilità del Cefaclor nella profi-lassi delle infezioni delle vie urinarie del bambino. Ped Med Chir 1996; 18: 383–385.
  • Nord CE, Heimdahl A, Lundberg C, Marklung G. Impact of cefaclor on the normal human oropharyngeal and intestinal microflora. Scand J Infect Dis 1987; 19: 681–685.
  • Nord CE, Edlund C. Impact of antimicrobial agents on lumen intestinal microflora. J Chemother 1990; 2: 218–237.
  • Cataldi L, Fanos V. Neonatal urinary tract infections: diagnosis and treatment. In L. Cataldi, V. Fanos, U. Simeoni, eds. Neonatal Nephrology in Progress. Lecce, Agora Edt, 1996: 183-198.
  • Grouhi M, Hummel D, Roifman CM. Anaphylactic reaction to oral cefaclor in a child. Paediatrics 1999; 103 (4): 50.
  • Stapleton P, Wu PJ, King A, Shannon R, French G, Phillips I. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia colt Antimicrob Agents Chemother 1995; 39: 2478-2483.
  • Weber P, Scotto M, Plaisance JJ, Mancy C, Chouteau J, Chef J. Activités in vitro de famoxicilline-acide clavulanique vis-a-vis d'Escherichia coli en medicine de ville. Med Mal Infect 1995; 25: 593–598.
  • Bemer-Melchior P, Gilly L, Jugroot-Klotz K, Brun T, Nevot P, Paul G. Resistance to amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolat-ed in 1992 at the Cochin Hospital. Pathol Biol 1995; 43 (9): 760–765.
  • Stapleton P, Wu PJ, King A, Shannon K, French G, Phillips I. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia colt Antimicrob Agents Chemother 1995; 39 (11): 2478-83
  • Margariti PA, Astorri AL, Mastromarino C. Urinary tract infections: risk factors and therapeutic trends. Recenti Prog Med 1997; 88 (2): 65–8.
  • Natsch S, Conrad C, Hartmeier C, Schmid B. Use of amoxicillin-clavulanate and resistance in Escherichia coli over a 4-year period. Infect Control Hosp Epidemiol 1998; 19 (9): 653–656.
  • Siu LK, Cheng WL, Ho PL, Ng WS, Chau PY, Lo JY. Correlation of in vitro susceptibility testing results for amoxi-cillin-clavulanate and ampicillin-sulbactam using a pannel of beta-lactamase-producing Enterobacteriaceae. APMIS 1998; 106 (9): 917–20.
  • Oliver A, Perez-Vazquez M, Martinez-Ferrer M, Baquero F, De Rafael L, Canton R. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes. Antimicrob Agents Chemother 1999; 43 (4): 862–7.
  • Naber KG. Fluoroquinolones in urinary tract infections. Proper and improper use. Drugs 1996; 52 (52): 27–33.
  • Brun P. Utilisation des quinolones dans le traitement des infections urinaires de l'enfant. In: Aujard Y, Genarel D, eds. Les quinolones en pedietrie. Paris: Flammarion Medecine - Sciences, 1998: 99–104.
  • Brun P, Mariani- Kurkdjian P. Traitement de l'infection urinaire de l'enfant. Archs Pediat 1996; 3: 81–84.
  • Fujii R. The use of norfloxacin in children in Japan. Adv Antimicrob Antineopl Chemother 1992; 11 (2): 219–232.
  • Van Wijk JAAE, De Jong TPVM, Van Gool JD. et al. Using quinolones in urinary tract infections in children. Adv Antimicrob Antineopl Chemother 1992; 11 (2): 157–165.
  • Fanos V, Khoory BJ, Vecchini S, PedroIli A, Pizzini C, Benini D. Ii reflusso vescico-ureterale in pediatria. MM Pediatr 1998; 50: 367–374.
  • Fanos V, Khoory BJ, Benini D et al. Rilevanza clinica delle uropatie malformative in pediatria. Ii Pediatra 1998; 15: 15–19.
  • Wennerstrom M, Hansson S, Jodal U, Stokland E. Disappearance of vesicoureteral reflux in children. Arch Pediatr Adolesc Med 1998; 152: 879–883.
  • Kazikaki H, Nomokura K, Yamashita T, Shibata T, Koyama T, Koyanagi T. Clinical features of vesicoureteral reflux in infants and outcome of conservative therapeutic approach. Eur Urol 1998; 34 (3): 221–225.
  • Pipsz A, Tamminen-Mobius T, Reiners C, et al. Five year study of medical or surgical treatment in children with severe vesicoureteral reflux dimercaptosuccinic acid findings. Eur J Pediatr 1998; 157: 753–758.
  • Ross JH, Kay R. Pediatric urinary tract and reflux. Am Fam Phys 1999; 59 (6): 1472–1478.
  • Smellie JM, Katz G, Grunenberg RN. Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet 1978; ii: 175–178.
  • Garin EH, Campos A, Homsy Y. Primary vesicoureter-al reflux: review of current concepts. Pediatr Nephrol 1998; 12: 249–256.
  • Greenfield SP, Manyan NG, Wan J. Experience with vesicoureteral reflux in children: clinical characteristics. J Urol 1997; 158: 574–577.
  • Dagan R, Powell KR, Hell CB, Menegus MA. Identification of infants unlikely to have serious bacterial infections, although hospitalized for suspected sepsis. J Pediatr 1985; 107: 855–860.
  • Botto H. Antibiotic prophylaxis in urology [in French]. Presse Med 1995; 24 (32): 1491–1493.
  • Uhari M, Nuutinen M, Turtinrn J. Adverse reactions in children during long term antimicrobial therapy. Pediatr Infect Dis J 1996; 15: 404–408.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.